How can you resolve the complexities of precision medicine to give cancer patients the best chance at the best outcomes?

Trapelo knows.

Trapelo is the first, interoperable, decision-support platform used by oncologists, labs, and payers that informs testing and treatment and facilitates real-time alignment in precision medicine. Trapelo streamlines clinical workflow and prior authorization, enabling value-based care while quickly giving patients the most appropriate, evidence-supported options when time matters most.

Learn more about what Trapelo knows:

How to standardize value-based precision medicine across the practice by knowing which patients to test, which panels to order, and which labs to use

For Cancer Centers

How to drive value and enhance reimbursement

For Testing Labs

Which tests and treatments are evidence-supported and should be reimbursed

For Health Plans

How to connect more cancer patients to new precision therapies and clinical trials

For Pharma

NEW WHITEPAPER

The Cost and Complexities of Treating Cancer are Astronomical—and on the Rise

Now, some US oncologists are collaborating with genomic labs and payers through an evidence-based technology to reduce treatment costs and improve patient outcomes. Read the abstract here.

Co-authors:

Debra Patt, M.D., Ph.D., MBA

Texas Oncology

Russ Ingersoll, Ph.D.

Trapelo Health

Download Whitepaper Now

Join the conversation

Listen to the award-winning podcast featuring today's precision medicine innovators.

Lee_Newcomer%20zetema_Crop_edited.jpg

0003_Luba Greenwood_Crop2.jpg

Jack West Head shot cropped.jpg

Quackenbush-2-(preferred).jpg

Featured Guests:

Mr. Chet Burrell, formerly CareFirst Blue Cross Blue Shield
Dr. Jack West, City of Hope
Lee Newcomer, ret. UnitedHealthcare
Clynt Taylor, Trapelo Health
Luba Greenwood, Google Life Sciences

Join the conversation

Now in Season 4! Listen to the award-winning podcast featuring today's precision medicine innovators.

Quackenbush-2-(preferred).jpg

Stephen Kingsmore headshot_02.png

Barbara Fortini (002)_SM.png

Rolfo_Headshot 2021 .png

Lee_Newcomer%20zetema_Crop_edited.jpg

Jack West Head shot cropped.jpg

0003_Luba Greenwood_Crop2.jpg

Guests include patient advocates, oncologists, educators, entrepreneurs, genomic scientists, pathologists, health plan executives and more including:

Dr. Karen Winkfield, Executive Director Meharry-Vanderbilt Alliance
Lisa Goldman and Tori Tomalia, lung cancer patients and ROS1der founders
Dr. Christian Rolfo, President of the International Society of Liquid Biopsy
Dr. John Quackenbush, Harvard School of Public Health
Dr. Christian Rolfo, President of the International Society of Liquid Biopsy
Erika Stringer-Reasor, University of Alabama Birmingham
Ali Rogin, Producer PBS NewsHour and breast cancer previvor
Barbara Fortini, PhD, Keck Graduate Institute
Dr. Clayton Yates, Tuskegee University
Dr. Lee Newcomer, ret. UnitedHealthcare
Dr. Windy Dean-Columb, Our Lady of Lourdes Regional Medical Center
Dr. Bruce Johnson, Dana Farber Cancer Institute
Dr. Jack West, City of Hope
Selin Kurnaz, Massive Bio
Clynt Taylor, Trapelo Health
Luba Greenwood, Google Life Sciences